![]() |
5th International AIDS ConferenceMontreal, Quebec, Canada — Jun 4-9, 1989 |
Int Conf AIDS 1989 Jun 4-9; 5:172 (abstract no. A.567)
Mezzaroma I, Papetti C, Pesce AM, D'Offizi GD, Pinter E, Luzi G, Aiuti F; Dept. of Allergy and Clinical Immunology, University of Rome "La Sapienza", Rome, Italy
OBJECTIVE: - To evaluate the re-classification risk in HIV-1 seropositive patients at various clinical stages according to the CDC system.
METHODS: - Patients belonging to at risk categories were included: 25 homosexuals, 211 drug addicts, 22 heterosexuals. They were classified at the first medical check according to the CDC system: 40 CDC-II, 218 CDC-III. Selected patients were admitted to a follow up protocol (24 and 36 months). Every 6 months a clinical update was performed.
RESULTS: - The percentage of re-classified patients is as it follows TABULAR DATA, SEE ABSTRACT VOLUME.
CONCLUSIONS: Immunological features and clinical evolution show that a high risk population is included in CDC-II patients, who appear less stable during the follow up (48% evoluted if compared with 30% of CDC-III).
890604
A567
Copyright © 1989 - International AIDS Society (IAS). Reproduction of this abstract (other than one copy for personal reference) must be cleared through the IAS.